167 related articles for article (PubMed ID: 31563279)
1. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
Chen Z; Hu H
Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer.
Shen H; Guo YL; Li GH; Zhao W; Zhang L
Comput Math Methods Med; 2021; 2021():9946015. PubMed ID: 34497666
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. The Identification of Key Gene Expression Signature in Prostate Cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract][Full Text] [Related]
5. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
6. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
Foj L; Filella X
Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
[TBL] [Abstract][Full Text] [Related]
7. Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis.
Meng L; Li Y; Ren J; Shi T; Men J; Chang C
DNA Cell Biol; 2019 May; 38(5):468-475. PubMed ID: 30835547
[TBL] [Abstract][Full Text] [Related]
8. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
9. An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes.
Thiemeyer H; Taher L; Schille JT; Packeiser EM; Harder LK; Hewicker-Trautwein M; Brenig B; Schütz E; Beck J; Nolte I; Murua Escobar H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768937
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
[TBL] [Abstract][Full Text] [Related]
11. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
[TBL] [Abstract][Full Text] [Related]
13. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
14. Random forest-based modelling to detect biomarkers for prostate cancer progression.
Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Ma Z; Wang J; Ding L; Chen Y
Medicine (Baltimore); 2020 Jul; 99(28):e21158. PubMed ID: 32664150
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
18. Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.
Rajan P; Stockley J; Sudbery IM; Fleming JT; Hedley A; Kalna G; Sims D; Ponting CP; Heger A; Robson CN; McMenemin RM; Pedley ID; Leung HY
BMC Cancer; 2014 Dec; 14():977. PubMed ID: 25519703
[TBL] [Abstract][Full Text] [Related]
19. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
[TBL] [Abstract][Full Text] [Related]
20. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
